SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001628280-23-038400 from UL Solutions Inc. (ULS)

UL Solutions Inc.
Date: Nov. 13, 2023 · CIK: 0001901440 · Accession: 0001628280-23-038400

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Referenced dates: October 25, 2023

Date
November 13, 2023
Author
/s/ Cathy A. Birkeland
Form
CORRESP
Company
UL Solutions Inc.

Letter

Document

330 North Wabash Avenue

Suite 2800

Chicago, Illinois 60611

Tel: +1.312.876.7700

Fax: +1.312.993.9767

www.lw.com

FIRM / AFFILIATE OFFICES

Austin Milan

Beijing Munich

Boston New York

Brussels Orange County

Century City Paris

Chicago Riyadh

Dubai San Diego

Düsseldorf San Francisco

Frankfurt Seoul

November 13, 2023

Hamburg Shanghai

Hong Kong Silicon Valley

Houston Singapore

London Tel Aviv

Los Angeles Tokyo

Madrid Washington, D.C.

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Trade & Services

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention: Taylor Beech, Mara Ransom

Keira Nakada, Theresa Brillant

Re: UL Solutions Inc.

Amendment No. 8 to Draft Registration Statement on Form S-1

Submitted on October 10, 2023

CIK No. 0001901440

Ladies and Gentlemen:

On behalf of our client, UL Solutions Inc. (the “Company”), set forth below are the Company’s responses to the comments of the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) in their letter dated October 25, 2023 relating to the Company’s Amendment No. 8 to the above-referenced draft registration statement. Concurrently with the submission of this letter, the Company has publicly filed the registration statement on Form S-1 (the “Registration Statement”), which reflects the revisions described herein and certain other updated information.

For ease of reference, the text of the comments in the Staff’s letter has been reproduced in italics herein, with the Company’s response immediately following each numbered comment. Unless otherwise indicated, capitalized terms used herein have the meanings assigned to them in Amendment No. 8.

November 13, 2023

Page 2

Risk Factors

Risks Relating to our Indebtedness, page 67

1. Revise to eliminate redundancy in this section, as it appears you repeat some risks, and enhance your risk factor discussion to quantify the amount of indebtedness you have incurred or will incur in the near future in order to put the magnitude of these risks in context.

Response: The Company respectfully acknowledges the Staff’s comment. In response, the Company has revised the disclosure on page 67 of the Registration Statement.

Anti-takeover provisions in our governing documents…, page 79

2. Please revise this risk factor to address the fact that from and after the Trigger Date, you will have a classified board, will not permit stockholders to act by written consent, will only permit special stockholders meetings to be called by the chairperson of your board of directors, your CEO or your board of directors, and will require a supermajority vote to amend your charter and bylaws.

Response: The Company respectfully acknowledges the Staff’s comment. In response, the Company has revised the disclosure on pages 78 and 79 of the Registration Statement.

Dilution, page 91

3. Please ensure that “pro forma” defined herein is consistent with the “pro forma” under your capitalization disclosure on page 89. In this regard, you reflect the net proceeds from the sale of $300 million notes, other borrowings of $200 million, and a $600 million payment of special cash dividend in your pro forma capitalization table.

Response: The Company respectfully acknowledges the Staff’s comment. In response, the Company has revised the disclosure on pages 89 and 91 of the Registration Statement.

Exhibits

4. We note that you intend to close your offering of 6.500% senior notes due 2028 on October 20, 2023. When available, please file the related notes, indenture, and registration rights agreement as exhibits to your registration statement, or tell us why you are not required to do so.

Response: The Company respectfully acknowledges the Staff’s comment. In response, the Company has revised the exhibit index on page II-3 of the Registration Statement.

* * *

November 13, 2023

Page 3

Should you have any comments or questions regarding the foregoing, please call me at (312) 876-7681 or e-mail me at cathy.birkeland@lw.com. Thank you in advance for your attention to this matter.

Very truly yours,
/s/ Cathy A. Birkeland

Show Raw Text
CORRESP
1
filename1.htm

Document

 330 North Wabash Avenue

 Suite 2800

 Chicago, Illinois  60611

 Tel: +1.312.876.7700

 Fax: +1.312.993.9767

 www.lw.com

 FIRM / AFFILIATE OFFICES

 Austin Milan

 Beijing Munich

 Boston New York

 Brussels Orange County

 Century City Paris

 Chicago Riyadh

 Dubai San Diego

 Düsseldorf San Francisco

 Frankfurt Seoul

November 13, 2023

 Hamburg Shanghai

 Hong Kong Silicon Valley

 Houston Singapore

 London Tel Aviv

 Los Angeles Tokyo

 Madrid Washington, D.C.

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Trade & Services

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention:     Taylor Beech, Mara Ransom

                     Keira Nakada, Theresa Brillant

Re:                UL Solutions Inc.

                     Amendment No. 8 to Draft Registration Statement on Form S-1

                     Submitted on October 10, 2023

                     CIK No. 0001901440

Ladies and Gentlemen:

On behalf of our client, UL Solutions Inc. (the “Company”), set forth below are the Company’s responses to the comments of the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) in their letter dated October 25, 2023 relating to the Company’s Amendment No. 8 to the above-referenced draft registration statement. Concurrently with the submission of this letter, the Company has publicly filed the registration statement on Form S-1 (the “Registration Statement”), which reflects the revisions described herein and certain other updated information.

For ease of reference, the text of the comments in the Staff’s letter has been reproduced in italics herein, with the Company’s response immediately following each numbered comment. Unless otherwise indicated, capitalized terms used herein have the meanings assigned to them in Amendment No. 8.

November 13, 2023

Page 2

Risk Factors

Risks Relating to our Indebtedness, page 67

1.    Revise to eliminate redundancy in this section, as it appears you repeat some risks, and enhance your risk factor discussion to quantify the amount of indebtedness you have incurred or will incur in the near future in order to put the magnitude of these risks in context.

Response: The Company respectfully acknowledges the Staff’s comment. In response, the Company has revised the disclosure on page 67 of the Registration Statement.

Anti-takeover provisions in our governing documents…, page 79

2.    Please revise this risk factor to address the fact that from and after the Trigger Date, you will have a classified board, will not permit stockholders to act by written consent, will only permit special stockholders meetings to be called by the chairperson of your board of directors, your CEO or your board of directors, and will require a supermajority vote to amend your charter and bylaws.

Response: The Company respectfully acknowledges the Staff’s comment. In response, the Company has revised the disclosure on pages 78 and 79 of the Registration Statement.

Dilution, page 91

3.    Please ensure that “pro forma” defined herein is consistent with the “pro forma” under your capitalization disclosure on page 89.  In this regard, you reflect the net proceeds from the sale of $300 million notes, other borrowings of $200 million, and a $600 million payment of special cash dividend in your pro forma capitalization table.

Response: The Company respectfully acknowledges the Staff’s comment. In response, the Company has revised the disclosure on pages 89 and 91 of the Registration Statement.

Exhibits

4.    We note that you intend to close your offering of 6.500% senior notes due 2028 on October 20, 2023.  When available, please file the related notes, indenture, and registration rights agreement as exhibits to your registration statement, or tell us why you are not required to do so.

Response: The Company respectfully acknowledges the Staff’s comment. In response, the Company has revised the exhibit index on page II-3 of the Registration Statement.

*     *     *

2

November 13, 2023

Page 3

Should you have any comments or questions regarding the foregoing, please call me at (312) 876-7681 or e-mail me at cathy.birkeland@lw.com. Thank you in advance for your attention to this matter.

Very truly yours,

/s/ Cathy A. Birkeland

Cathy A. Birkeland

of Latham & Watkins LLP

cc:

  Jennifer F. Scanlon, UL Solutions Inc.

  Ryan D. Robinson, UL Solutions Inc.

  Jacqueline K. McLaughlin, UL Solutions Inc.

  Christopher D. Lueking, Latham & Watkins LLP

  Alexa M. Berlin, Latham & Watkins LLP

  Alexander D. Lynch, Weil, Gotshal & Manges LLP

  Barbra J. Broudy, Weil, Gotshal & Manges LLP

3